Danaher Corporation vs Stitch Fix Inc — how do they compare? Danaher Corporation trades at $199.47 (market cap $140.88B), while Stitch Fix Inc trades at $3.53 (market cap $495.68M). The key difference: Danaher Corporation is far larger — about 284.2× Stitch Fix Inc's market cap, and Danaher Corporation pays a 0.8% dividend while Stitch Fix Inc pays none. Which is the better fit depends on your goals.
| DHR | SFIX | |
|---|---|---|
Market Cap | $140.88B | $495.68M |
Sector | Health | Consumer Cyclical |
52-Week High | $242.05 | $5.83 |
52-Week Low | $161.91 | $3.06 |
Enterprise Value | $153.66B | $383.39M |
Dividend Yield | 0.8% | — |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $199.05, showing minimal daily change, with a bullish technical signal supported by moving averages. The company maintains strong profitability with a 58.94% gross margin and has beaten earnings estimates for the last three quarters. Recent news highlights the acquisition of Masimo and new product launches in its SCIEX division, indicating growth initiatives. Cash flow improved in 2025 to a net inflow of $2.54 billion, though revenue growth remains modest.
The outlook is positive with a consensus price target of $211.33, representing a 6% upside, and 69% of analysts rate it a buy. Risks include slowing revenue growth, high valuation multiples, and integration challenges from acquisitions. The stock offers a dividend yield supported by stable cash flows, but investors should monitor competitive pressures in the life sciences sector.
Stitch Fix (SFIX) trades at $3.62, up 1.69% on the day, as the stock shows signs of stabilization after a significant YTD decline. Recent quarters have seen narrowing losses, with Q1 2026 EPS beating expectations, and the company has returned to active client growth. The technical picture remains bearish, but improving fundamentals and AI-driven personalization efforts are key highlights. Analyst consensus is mixed, with a $4.75 price target suggesting potential upside from current levels.
The outlook for SFIX hinges on its turnaround execution, with revenue stabilization and margin improvement offering a path to profitability. Key risks include consumer spending pressures and competitive threats. While the stock trades near historic lows, positive earnings surprises and strategic AI investments present a speculative opportunity for value-oriented investors, balanced by ongoing net losses and cash flow challenges.
Trailing returns across standard periods
Latest headlines on both assets
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →